109 related articles for article (PubMed ID: 11063872)
1. An inhibitor of PI3-K differentially affects proliferation and IL-6 protein secretion in normal and leukemic myeloid cells depending on the stage of differentiation.
Birkenkamp KU; Esselink MT; Kruijer W; Vellenga E
Exp Hematol; 2000 Nov; 28(11):1239-49. PubMed ID: 11063872
[TBL] [Abstract][Full Text] [Related]
2. PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinase and p53 pathways.
Grandage VL; Gale RE; Linch DC; Khwaja A
Leukemia; 2005 Apr; 19(4):586-94. PubMed ID: 15703783
[TBL] [Abstract][Full Text] [Related]
3. Constitutive NF-kappaB DNA-binding activity in AML is frequently mediated by a Ras/PI3-K/PKB-dependent pathway.
Birkenkamp KU; Geugien M; Schepers H; Westra J; Lemmink HH; Vellenga E
Leukemia; 2004 Jan; 18(1):103-12. PubMed ID: 14574326
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of interleukin-3 and interleukin-1 on the proliferation and interleukin-6 protein secretion of acute myeloid leukemic cells; the involvement of ERK, p38 and STAT5.
Birkenkamp KU; Esselink MT; Kruijer W; Vellenga E
Eur Cytokine Netw; 1999 Dec; 10(4):479-90. PubMed ID: 10586114
[TBL] [Abstract][Full Text] [Related]
5. Sensitisation of HL60 human leukaemic cells to cytotoxic drug-induced apoptosis by inhibition of PI3-kinase survival signals.
O'Gorman DM; McKenna SL; McGahon AJ; Knox KA; Cotter TG
Leukemia; 2000 Apr; 14(4):602-11. PubMed ID: 10764145
[TBL] [Abstract][Full Text] [Related]
6. PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas.
Nakamura JL; Karlsson A; Arvold ND; Gottschalk AR; Pieper RO; Stokoe D; Haas-Kogan DA
J Neurooncol; 2005 Feb; 71(3):215-22. PubMed ID: 15735908
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol 3-kinase regulates PMA-induced differentiation and superoxide production in HL-60 cells.
Park SJ; Kang SY; Kim NS; Kim HM
Immunopharmacol Immunotoxicol; 2002 May; 24(2):211-26. PubMed ID: 12066848
[TBL] [Abstract][Full Text] [Related]
8. Growth inhibition of human malignant glioma cells induced by the PI3-K-specific inhibitor.
Shingu T; Yamada K; Hara N; Moritake K; Osago H; Terashima M; Uemura T; Yamasaki T; Tsuchiya M
J Neurosurg; 2003 Jan; 98(1):154-61. PubMed ID: 12546364
[TBL] [Abstract][Full Text] [Related]
9. Constitutive phosphorylation of the S6 ribosomal protein via mTOR and ERK signaling in the peripheral blasts of acute leukemia patients.
Chow S; Minden MD; Hedley DW
Exp Hematol; 2006 Sep; 34(9):1183-91. PubMed ID: 16939811
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1beta up-regulates inducible nitric oxide by way of phosphoinositide 3-kinase-dependent in a cochlear cell model.
Nam SI
Laryngoscope; 2006 Dec; 116(12):2166-70. PubMed ID: 17146391
[TBL] [Abstract][Full Text] [Related]
11. [The PI3K/Akt/mTOR pathway: a new therapeutic target in the treatment of acute myeloid leukemia].
Dos Santos C; Récher C; Demur C; Payrastre B
Bull Cancer; 2006 May; 93(5):445-7. PubMed ID: 16777621
[TBL] [Abstract][Full Text] [Related]
12. Insulin-stimulated cell growth in insulin receptor substrate-1-deficient ZR-75-1 cells is mediated by a phosphatidylinositol-3-kinase-independent pathway.
Gliozzo B; Sung CK; Scalia P; Papa V; Frasca F; Sciacca L; Giorgino F; Milazzo G; Goldfine ID; Vigneri R; Pezzino V
J Cell Biochem; 1998 Aug; 70(2):268-80. PubMed ID: 9671232
[TBL] [Abstract][Full Text] [Related]
13. [PI3-kinase inhibitors LY294002 and wortmannin have different effects on proliferation of murine embryonic stem cells].
Lianguzova MS; Chuĭkin IA; Nordheim A; Pospelov VA
Tsitologiia; 2006; 48(7):560-8. PubMed ID: 17087147
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidylinositol 3-kinase inhibitors prevent mouse cytotoxic T-cell development in vitro.
Phu T; Haeryfar SM; Musgrave BL; Hoskin DW
J Leukoc Biol; 2001 May; 69(5):803-14. PubMed ID: 11358990
[TBL] [Abstract][Full Text] [Related]
15. Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors.
Takeuchi H; Kondo Y; Fujiwara K; Kanzawa T; Aoki H; Mills GB; Kondo S
Cancer Res; 2005 Apr; 65(8):3336-46. PubMed ID: 15833867
[TBL] [Abstract][Full Text] [Related]
16. The phosphatidylinositol 3-kinase/Akt signaling pathway modulates the endocrine differentiation of trophoblast cells.
Kamei T; Jones SR; Chapman BM; MCGonigle KL; Dai G; Soares MJ
Mol Endocrinol; 2002 Jul; 16(7):1469-81. PubMed ID: 12089343
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells.
Uddin S; Hussain AR; Al-Hussein KA; Manogaran PS; Wickrema A; Gutierrez MI; Bhatia KG
Clin Cancer Res; 2005 Apr; 11(8):3102-8. PubMed ID: 15837766
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells.
Ikezoe T; Nishioka C; Bandobashi K; Yang Y; Kuwayama Y; Adachi Y; Takeuchi T; Koeffler HP; Taguchi H
Leuk Res; 2007 May; 31(5):673-82. PubMed ID: 17007924
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.
Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ
Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789
[TBL] [Abstract][Full Text] [Related]
20. Stabilization of cyclin D1 mRNA via the phosphatidylinositol 3-kinase pathway in MCF-7 human breast cancer cells.
Dufourny B; van Teeffelen HA ; Hamelers IH; Sussenbach JS; Steenbergh PH
J Endocrinol; 2000 Aug; 166(2):329-38. PubMed ID: 10927622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
